Pharma

Pharma

E-pharma set to revolutionize drug market access in India as COVID-19 drives e-commerce growth, says GlobalData

The COVID-19 induced lockdown resulted in an unprecedented rise in e-commerce transactions across India. In line with this, e-pharma sector also witnessed growth despite regulatory challenges. Against this backdrop, e-pharma space is all set to revolutionize drug market access in the country, says GlobalData, a leading data and analytics company. Anupama Mishra, Pharma Analyst at […]

Pharma

Neovascularization inhibitor sales will near $7bn in diabetic retinopathy market in 2029, says GlobalData

The diabetic retinopathy (DR) market has been dominated by neovascularization inhibitors, and this group of therapies is expected to generate more than $6.8bn in sales in the DR market in 2029, rising from $3.2bn in 2019 at a compound annual growth rate (CAGR) of 7.8%. This increase is expected to be driven by the demonstrable […]

Pharma

Few CMOs are equipped to manufacture cell and gene therapies

As more than 7,000 cell and gene therapies progress through the development pipeline and only 152 CMOs have the capabilities to manufacture them, production bottlenecks are the major obstacle to large-scale commercial manufacture once more Advanced Therapy Medicinal Products (ATMPs) are approved, says GlobalData, a leading data and analytics company. Currently, 79 of these cell […]

Pharma

Three-quarters of specialists increased use of telemedicine during COVID-19 pandemic

A total 73% of cardiology, gastroenterology, pulmonology, and respiratory specialists in the US, Europe, the UK and Japan indicated that their use of telemedicine has increased as a result of the pandemic, according to a survey by data and analytics firm GlobalData. Kathryn Whitney, MSc, Director of Thematic Analysis at GlobalData, comments: “Approximately two-thirds of […]

Pharma

Brazil’s high COVID-19 case count allows for clinical trials to progress, says GlobalData

While the COVID-19 pandemic continues to cause high numbers of confirmed new cases in Brazil, the patient population available for the increasing number of COVID-19 clinical trials should allow these to continue to completion, says GlobalData, a leading data and analytics company. Scotty Chung-Siu, MPH, Senior Analyst at GlobalData, comments: “The number of COVID-19 cases […]

Pharma

Small-cap companies have 85% of the COVID-19 pipeline of small-cap and mid-cap candidates

A total of 198 small- and mid-cap Bio/Pharma companies are currently involved in vaccine or therapeutic development for COVID-19, with a total of 244 unique candidates in the pipeline from these companies. Of these, small-cap companies have the largest proportion of the pipeline candidates for COVID-19 (85%), either the discovery or preclinical stages. This indicates […]

Pharma

Sanofi impacted by disrupted clinical trials and lagging vaccine development due to COVID-19, says GlobalData

Sanofi’s progress in research and development (R&D) has been adversely impacted by the COVID-19 pandemic. As of late August, six of Sanofi’s clinical trials, which were being conducted in 31 countries, have been disrupted, with most of the disruptions being in Phase II and III – including two pivotal trials. These delays will impact regulatory […]

Pharma

RPGR is the most common target for gene therapies in pipeline development for retinitis pigmentosa

Gene therapies dominate the pipeline landscape for retinitis pigmentosa (RP) with the gene coding for retinitis pigmentosa GTPase regulator (RPGR) the most common target among these therapies for retinitis pigmentosa (RP), according to the latest research by GlobalData, a leading data and analytics company. Vinie Varkey, Senior Ophthalmology Analyst at GlobalData, comments: “RP is a […]

Pharma

NHS soup-and-shake diet could lead to reduction in type 2 diabetes and obesity in UK by improving disease management, says GlobalData

Following the news that Type 2 diabetes sufferers in the UK were put on a soup and shake diet by the NHS; Akash Patel, Cardiovascular & Metabolic Disorders Analyst at GlobalData, offers their view: “Plans like the NHS’ soup-and-shake diet will help the ~1.9 million people in the UK that are estimated by GlobalData to […]

Pharma

67% of healthcare experts plan to use decentralized clinical trials in the near future due to COVID-19, says GlobalData

Healthcare experts have noted that their number one primary concern amid the COVID-19 pandemic was the delay to initiation or inability to conduct clinical trials, according to a recent survey by GlobalData*. This is not a surprise, as the data and analytics company notes that at peak over 1,200 clinical trials experienced some level of […]

Pharma

AbbVie’s Rinvoq a strong new contender in AS but may struggle due to high competition, says GlobalData

If AbbVie is successful with its FDA application submission for JAK inhibitor Rinvoq in adult patients with ankylosing spondylitis (AS), the drug is expected to greatly increase its patient pool – accumulating 2028 sales of $113m in AS across the seven major markets (7MM*) – but may have a tough time to gain ground in […]

Pharma

Government reimbursement for dialysis patients on AstraZeneca/FibroGen’s roxadustat faces fiscal challenges, says GlobalData

Reimbursement for dialysis patients on AstraZeneca’s/FibroGen’s roxadustat needs to be untangled such that it can be billed separately and be accompanied by hikes in eventual payment bundles, as reported by Manasi Vaidya, Pharma Writer for the Investigative News team at GlobalData, a leading data and analytics company. Vaidya comments: “Clarity on how the US Centers […]

Pharma

India’s proposed new agile pharma regulations will benefit innovator companies, says GlobalData

India is overhauling its pharma regulatory norms to expedite approval process and promote innovation. Given that the country is now focused more than ever on developing novel therapies and vaccines on account of the COVID-19 situation, the move will not only remove unnecessary procedural roadblocks but also foster innovation, says GlobalData, a leading data and […]

Pharma

EUA for convalescent plasma likely being used as political spin and more robust data is required, says GlobalData

Following the news that the FDA granted an EUA for convalescent plasma as a treatment option for COVID-19; Angad Lotay MPharm, Infectious Diseases Analyst at GlobalData, offers his view: “Granting convalescent plasma an EUA was a critical decision in which the public should be able to have confidence. However, the data was presented during a […]

Pharma

Gilead, AstraZeneca and Pfizer likely to emerge as winners of COVID-19 therapeutics and vaccine development race, says GlobalData

More than 1,200 therapeutics and vaccines have entered the research and development (R&D) pipeline since January 2020, according to GlobalData, a leading data and analytics company, and that number grows every week. According to GlobalData’s Clinical and Commercial Analyzer tool, which rates the most promising and high-profile assets on a range of clinical and commercial […]

Pharma

Over three-quarters of US specialists increased use of telemedicine during the COVID-19 pandemic, says GlobalData

Use of telemedicine by US physicians has increased significantly as a result of the COVID-19 outbreak. In a survey conducted by data and analytics company GlobalData*, 79% of specialists indicated that their use of telemedicine technology had increased as a result of the pandemic, while 20% indicated that their use had stayed the same. Kathryn […]

Pharma

Market for graft versus host disease across five APAC markets to grow at 8.2% CAGR over next 10 years, says GlobalData

The market for graft versus host disease (GvHD) prophylaxis and treatment in the five growth markets (5GM*) in the Asia-Pacific (APAC) region will undergo steady growth at a compound annual growth rate (CAGR) of 8.2% from 2018 to 2028, according to GlobalData, a leading data and analytics company. GlobalData’s latest report, ‘Graft Versus Host Disease […]

Pharma

Delaying digital hospital-to-pharmacy referral scheme will continue to stretch the NHS, says GlobalData

The digital hospital-to-pharmacy referral scheme is taking time to materialize despite the significant benefits it would provide to the UK. With adverse drug events being one of the most common post-discharge complications in the country, the initiative would be a further step ahead in solving healthcare capacity constraints and help the UK meet WHOs target to […]

Pharma

38% of healthcare participants see promise in mRNA vaccines, says GlobalData

In a recent GlobalData poll* 38% felt that mRNA COVID-19 vaccines are the most promising of the vaccine technologies, noticeably beating DNA vaccines, which only accounted for 9%. While mRNA may currently be leading the way, other vaccine candidates by Sanofi/GSK and AstraZeneca are soon catching up. Johanna Swanson, Product Manager at GlobalData, comments: “GSK […]

Pharma

Phase II results show promise for soticlestat in Dravet Syndrome, says GlobalData

Following the news that Takeda and Ovid’s epilepsy drug soticlestat achieved positive Phase II trial results in children with hard-to-treat epilepsy syndromes; Philippa Salter, Neurology Analyst at GlobalData, a leading data and analytics company, offers her view: “While the trial ELEKTRA as a whole met its primary endpoint, demonstrating a reduction in seizure frequency, soticlestat […]

Prev 1 … 80 81 82 83 84 … 108 Next

E-pharma set to revolutionize drug market access in India as COVID-19 drives e-commerce growth, says GlobalData

Neovascularization inhibitor sales will near $7bn in diabetic retinopathy market in 2029, says GlobalData

Few CMOs are equipped to manufacture cell and gene therapies

Three-quarters of specialists increased use of telemedicine during COVID-19 pandemic

Brazil’s high COVID-19 case count allows for clinical trials to progress, says GlobalData

Small-cap companies have 85% of the COVID-19 pipeline of small-cap and mid-cap candidates

Sanofi impacted by disrupted clinical trials and lagging vaccine development due to COVID-19, says GlobalData

RPGR is the most common target for gene therapies in pipeline development for retinitis pigmentosa

NHS soup-and-shake diet could lead to reduction in type 2 diabetes and obesity in UK by improving disease management, says GlobalData

67% of healthcare experts plan to use decentralized clinical trials in the near future due to COVID-19, says GlobalData

AbbVie’s Rinvoq a strong new contender in AS but may struggle due to high competition, says GlobalData

Government reimbursement for dialysis patients on AstraZeneca/FibroGen’s roxadustat faces fiscal challenges, says GlobalData

India’s proposed new agile pharma regulations will benefit innovator companies, says GlobalData

EUA for convalescent plasma likely being used as political spin and more robust data is required, says GlobalData

Gilead, AstraZeneca and Pfizer likely to emerge as winners of COVID-19 therapeutics and vaccine development race, says GlobalData

Over three-quarters of US specialists increased use of telemedicine during the COVID-19 pandemic, says GlobalData

Market for graft versus host disease across five APAC markets to grow at 8.2% CAGR over next 10 years, says GlobalData

Delaying digital hospital-to-pharmacy referral scheme will continue to stretch the NHS, says GlobalData

38% of healthcare participants see promise in mRNA vaccines, says GlobalData

Phase II results show promise for soticlestat in Dravet Syndrome, says GlobalData

Browse

Company information